Additional Information
Size: |
100 µl |
Target: |
Aurora B |
Conjugate: |
Dylight 594 |
Research Area: |
Cancer | Cell Cycle | Cell Division | Spindle | Cell Signaling | Protein Phosphorylation | Serine / Threonine Kinases | Aurora |Cell Signaling | Protein Phosphorylation | Epigenetics and Nuclear Signaling | Chromatin Modifying Enzymes |
Alternative Name: |
AIK2 Antibody, ARK2 Antibody, Aurora related Kinase 2 Antibody, IPL1 Antibody, STK1 Antibody, Aurora 1 Antibody |
Category: |
Antibodies |
Product Type: |
Polyclonal Antibody |
Immunogen: |
Synthetic peptide of human Aurora B (AA2-16) |
Immunogen Species: |
Human |
Applications: |
WB, AM |
Host: |
Rabbit |
Isotype: |
N/A |
Species Reactivity: |
Human, Mouse |
Antibody Dilution: |
WB (1:250); optimal dilutions for assays should be determined by the user. |
Purification: |
Peptide Affinity Purified |
Storage Buffer: |
PBS pH7.4, 50% glycerol, 0.025% Thimerosal |
Concentration: |
N/A |
Specificity: |
Detects 39.28 kDa. |
Storage: |
-20ºC |
Shipping: |
Blue Ice or 4ºC |
Certificate of Analysis: |
A 1:250 dilution of SPC-1107 was sufficient for detection of Aurora B in 10 µg of HeLa cell lysate by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody. |
Cellular Localization: |
Nucleus, Cytoplasm, Cytoskeleton |
Tissue Specificity: |
High level expression seen in the thymus. It is also expressed in the spleen, lung, testis, colon, placenta and fetal liver. Expressed during S and G2/M phase and expression is up-regulated in cancer cells during M phase |
Accession Number: |
NP_004208 |
Gene ID: |
9212 |
Swiss-Prot: |
Q96GD4 |
Field of Use: |
For in vitro research use only. |